Zefei Jiang, Ting Luo, Haifeng Liu, Xu Wang, Tao Wang, Huihui Li, Jin Yang, Yang Li, Min Yan, Yongmei Yin, Jing Yao, Jingruo Li, Yueyin Pan, Xiaoyu Zhu, Wenjie Xin, Dapeng Zhang. "HRS-8080, an oral selective estrogen receptor degrader (SERD), in ER+/HER2− advanced breast cancer (aBC) with
                    <i>ESR1</i>
                    mutations (
                    <i>ESR1</i>
                    m): Results from a first-in-human phase 1 trial.." Journal of Clinical Oncology, 2026. doi:10.1200/jco.2026.44.16_suppl.1069